but some believe that the acquisition will pay off for the big pharma company. It needs new products to succeed its flagship product, Humira, which will face biosimilar competition in the near future.

Incentive structure: Big pharma ... or companies fail. Only a tiny few biotech innovations will become globally impactful successes. Further, it can take 10-20 years for innovations to pay off.

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses ... should the various bets pay off. Sanofi has been ...

I see the desire everywhere to win for this company, along with a willingness ... the right incentive systems, is starting to pay off. With the gap to market was all on kind of large contract ...

With the company continuing to capitalize on its pipeline, things just got better the other day for this company and its shareholders. Why is that? That's because big pharmaceutical powerhouse ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

President Donald Trump brought drug prices into focus this week when he vowed to cut medication costs by mandating that pharmaceutical companies ... with other Big Pharma-funded groups, notably ...

At nearly 750,000 entries, the dataset of transactions between companies and medical practitioners in Cincinnati was ...

President Donald Trump took on Big Pharma Monday with an executive ... is home to only 4% of the world’s population, pharmaceutical companies make more than two thirds of their profits in ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...